# Synthetic Biology * **Definition:** An interdisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems, or re-engineer existing ones. * **Taxonomy:** Healthcare Topics / Synthetic Biology ## News * Selected news on the topic of **Synthetic Biology**, for healthcare technology leaders * 13.6K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**The AI threat to public health no one is thinking about: a fake bioterrorist attack - STAT News**](https://www.statnews.com/2025/05/27/artificial-intelligence-bioterrorism-deepfake-public-health-threat/) | [[STAT]] | | 5/17/2025 | [**Synthetic Biology Tools Market Size and Trends: What to Expect in the Coming Years**](https://www.linkedin.com/pulse/synthetic-biology-tools-market-size-trends-what-ggopf) | [[Linkedin]] | | 5/16/2025 | [**Driving Synthetic Biology Forward Through Adoption of Technology Enabling Rapid DNA and mRNA Synthesis**](https://medcitynews.com/2025/05/driving-synthetic-biology-forward-through-adoption-of-technology-enabling-rapid-dna-and-mrna-synthesis/) | [[MedCity News]] | | 4/9/2025 | [**Synthetic Biology Platforms Market to Reach $14.10 Billion by 2030, Growing at ... - Yahoo Finance**](https://finance.yahoo.com/news/synthetic-biology-platforms-market-reach-090700097.html) | [[Yahoo Finance]] | | 3/10/2025 | [**The California crisis in homeowners insurance has only one real solution - Fortune**](https://fortune.com/2025/03/10/california-homeowners-insurance-crisis/) | [[Fortune]] | | 2/19/2025 | [**Synthetic Biology in Australia, China, and India: Insights from Asia and Pacific Research ...**](https://www.prnewswire.com/news-releases/synthetic-biology-in-australia-china-and-india-insights-from-asia-and-pacific-research-center-japan-science-and-technology-agency-302378929.html) | [[PR Newswire]] | | 2/19/2025 | [**Synthetic Biology in Australia, China, and India: Insights from Asia and Pacific Research ...**](https://finance.yahoo.com/news/synthetic-biology-australia-china-india-133100531.html) | [[Yahoo Finance]] | | 2/1/2025 | [**Scientists Just Achieved a Major Milestone in Creating Synthetic Life - Yahoo**](https://www.yahoo.com/news/scientists-just-achieved-major-milestone-200012464.html) | [[Yahoo]] | | 1/25/2025 | [**Synthetic Biology + AI: Transforming the Future of Biotechnology - by Shivansh Midha**](https://medium.com/@midhashivansh/synthetic-biology-ai-transforming-the-future-of-biotechnology-6cd9d9cbf016) | [[Medium]] | | 1/9/2025 | [**Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma ...**](https://finance.yahoo.com/news/rapid-rise-synthetic-biology-fuels-163800694.html) | [[Yahoo Finance]] | | 1/7/2025 | [**Synthetic Biology Market Research 2024-2034 - Yahoo Finance**](https://finance.yahoo.com/news/synthetic-biology-market-research-2024-115300186.html) | [[Yahoo Finance]] | | 12/19/2024 | [**Synthetic Biology Market Growth from 2024 to 2031, Projected at 12AGR, Highlighting ...**](https://www.linkedin.com/pulse/synthetic-biology-market-growth-from-2024-2031-projected-iyxhf) | [[Linkedin]] | | 12/12/2024 | [**Synthetic Biology Market Worth $12.33 Billion in 2024, is Forecast to Generate Revenues of ...**](https://finance.yahoo.com/news/synthetic-biology-market-worth-12-093400779.html) | [[Yahoo Finance]] | | 12/9/2024 | [**Synthetic Biology Focused Insights Report 2024-2029 with Competitive Analysis of 38 Vendors - Agilent, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific Lead - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241209196246/en/Synthetic-Biology-Focused-Insights-Report-2024-2029-with-Competitive-Analysis-of-38-Vendors---Agilent-Codexis-Eurofins-Scientific-Illumina-Novozymes-and-Thermo-Fisher-Scientific-Lead---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/4/2024 | [**Synthetic Biology Market to Hit USD 31.52 Billion by 2029 with 20.6AGR - MarketsandMarkets™.**](https://www.globenewswire.com/news-release/2024/12/04/2991380/0/en/Synthetic-Biology-Market-to-Hit-USD-31-52-Billion-by-2029-with-20-6-CAGR-MarketsandMarkets.html) | [[Globe Newswire]] | | 11/22/2024 | [**Synthetic Biology Tools Market - A Global and Regional Analysis - LinkedIn**](https://www.linkedin.com/pulse/synthetic-biology-tools-market-global-regional-analysis-wdrbc) | [[Linkedin]] | | 11/19/2024 | [**Clinical Data Analytics Solutions Market Forecast to 2034 by Solution, Application, End-user ...**](https://finance.yahoo.com/news/clinical-data-analytics-solutions-market-094400058.html) | [[Yahoo Finance]] | | 11/11/2024 | [**Synthetic Biology Market to Hit USD 31.52 Billion by 2029 with 20.6AGR - PR Newswire**](https://www.prnewswire.com/news-releases/synthetic-biology-market-to-hit-usd-31-52-billion-by-2029-with-20-6-cagr--marketsandmarkets-302300950.html) | [[PR Newswire]] | | 9/19/2024 | [**Synthetic Biology Market to Grow by USD 55.60 billion (2024-2028), AI Driven Innovations ...**](https://www.lelezard.com/en/news-21532480.html) | lelezard.com | | 9/8/2024 | [**Pharma's use of synthetic biology could deliver radical innovation**](https://pharmaphorum.com/r-d/pharma-synthetic-biology-radical-innovation) | [[Pharma Phorum]] | | 8/1/2024 | [**Angel Yeast Brings Together Innovative Consortium to Build Industrial Park for Synthetic Biology Development**](https://www.prnewswire.com/news-releases/angel-yeast-brings-together-innovative-consortium-to-build-industrial-park-for-synthetic-biology-development-302211262.html) | [[PR Newswire]] | | 8/1/2024 | [**Angel Yeast Brings Together Innovative Consortium to Build Industrial Park for Synthetic Biology Development**](https://www.prnewswire.com/news-releases/angel-yeast-brings-together-innovative-consortium-to-build-industrial-park-for-synthetic-biology-development-302211093.html) | [[PR Newswire]] | | 7/21/2024 | [**Synthetic Biology Market Size, Share, Growth, and Forecast 2023-2032 - WhaTech**](https://www.whatech.com/og/markets-research/medical/859265-synthetic-biology-market-size-share-growth-and-forecast-2023-2032) | whatech.com | | 6/27/2024 | [**Researchers propose a new, holistic way to teach synthetic biology**](https://phys.org/news/2024-06-holistic-synthetic-biology.html) | [[Phys Org]] | | 4/5/2023 | [**In a world of synthetic biology, publishing virus DNA sequences may mean perishing**](https://www.statnews.com/2023/04/06/synthetic-biology-publishing-virus-sequences/) | [[STAT]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Twist Bioscience**: A leading company in synthetic biology and gene synthesis, known for its innovative DNA synthesis technology. - **bit.bio**: A synthetic biology company focused on coding human cells for innovative cures. - **GenScript**: A biotechnology company specializing in gene synthesis and protein production, contributing to advancements in synthetic biology. - **Synthace**: Offers a digital experiment platform for automated experiments in synthetic biology. - **Moderna**: Known for its COVID-19 vaccine, showcasing the practical applications of synthetic biology in drug development. - **Shenzhen Synthetica Pioneering Co., Ltd.**: A startup focused on synthetic biology and bacterial therapeutics, particularly in oncolytic therapies. - **Thermo Fisher Scientific**: A leading company in synthetic biology, focusing on genetic engineering and biomanufacturing. - **Twist Bioscience Corporation**: A leader in synthetic DNA manufacturing, utilizing a proprietary silicon-based platform for various applications in healthcare and agriculture. - **Beijing Tsingke Biotech Co., Ltd.**: Specializes in synthetic materials and gene synthesis services, showcasing innovations in cell and gene therapy. - **Verge Genomics**: Utilizes AI to accelerate drug discovery, focusing on synthetic biology applications. - **Merck KGaA**: A prominent company in the synthetic biology sector, focusing on product development and strategic partnerships. - **Olfactive Biosolutions**: A biotech firm innovating in olfactory technology for health and wellness, leveraging synthetic biology. - **Integrated DNA Technologies (IDT)**: A leading provider of synthetic biology products, including rapid genes and gene synthesis services, enhancing drug discovery and research efficiency. - **Angel Yeast**: A leader in yeast manufacturing, launching initiatives to advance synthetic biology technology. - **Telesis Bio**: Partnering with Beckman Coulter Life Sciences to enhance DNA synthesis capabilities. - **Trogenix Ltd**: A biotech startup utilizing synthetic biology and machine learning for precision cancer treatment. - **GenScript Biotech**: A prominent player in the enzymatic DNA synthesis market, providing comprehensive data on market trends. ### Partnerships and Collaborations - **DBN Group and Global Scientists**: Partnerships aimed at advancing synthetic biology and gene editing through the ZGC BioIntelligent Manufacturing Innovation Center. - **Bristol Center for Engineering Biology and Jean Golding Institute**: Collaborative effort to enhance safety in synthetic biology through the identification of data-centric hazards. - **Telesis Bio and Beckman Coulter Life Sciences**: Collaborating to develop efficient biofoundries for on-premise DNA synthesis. - **Angel Yeast Consortium**: Forming a consortium with universities and enterprises to advance synthetic biology technology. - **Yong Loo Lin School of Medicine**: Engineered yeast for precision medicine applications, showcasing collaboration in synthetic biology research. - **Twist Bioscience and Ildong Pharmaceutical**: Collaboration focused on developing synthetic DNA offerings and antibody discovery capabilities. - **TheraSyn Bio and Rubix LS**: Joint venture named Project Panacea aimed at developing a topical breast cancer therapy integrating synthetic biology and AI. - **Olfactive Biosolutions' Scientific Advisory Board**: Composed of experts in biotechnology and synthetic biology to enhance health innovations. - **MojiaBio and A*STAR**: Collaboration to launch a Sustainable Biomanufacturing Technology Platform for producing eco-friendly bio-based molecules. - **National Science Foundation and UC Santa Barbara**: A $22 million grant awarded to establish the BioFoundry for Extreme and Exceptional Fungi, Archaea, and Bacteria, focusing on synthetic biology research. - **Shenzhen Synthetica and Boehringer Ingelheim**: Synthetica secured Series A funding led by Boehringer Ingelheim to develop oncolytic bacterial therapies for solid tumors. - **BD and Hamilton**: BD's OMICS-One XT WTA Assay integrates with Hamilton's Microlab NGS STAR platform to enhance genomics workflows. - **AI Proteins and Bristol Myers Squibb**: Collaborating to develop novel miniprotein-based therapeutics, potentially worth up to $400 million. - **Twist Bioscience and XOMA Royalty Corporation**: Twist entered a royalty purchase agreement with XOMA to enhance its financial position and support ongoing innovation in biopharma services. - **Novotech and Beijing Biostar Pharmaceuticals**: A strategic partnership to enhance clinical research and support Biostar's development plans. - **Amyris and GMP-manufacturing partners**: Collaborating to develop small molecule drugs targeting FDA drug shortages. - **University of Queensland and various research institutions**: Collaborating to advance high-quality vaccine candidates towards clinical trials. - **Texas A&M Health and BurstIQ**: Partnering to enhance clinical research through improved data management and patient privacy. - **GE HealthCare and Amazon Web Services**: Collaboration to develop AI models for automating diagnostics using anonymized X-ray images. ### Innovations, Trends, and Initiatives - **Synthetic Biology Platforms**: Combining automation with advanced synthesis chemistry to enable rapid synthesis with minimal hands-on time. - **Synthetic Biology Market Growth**: Projected CAGR of 12% from 2024 to 2031, driven by advancements in genetic engineering and bioinformatics. - **AI in Synthetic Biology**: Integration of AI with synthetic biology is enhancing drug discovery, genetic engineering, and personalized medicine. - **Synthetic Biology Tools Market Growth**: Projected to grow at a CAGR of approximately 25% from 2023 to 2030, driven by technological advancements and cost-effectiveness. - **AI and Robotics Integration**: Emerging trends in synthetic biology include the integration of AI and robotics for enhanced research capabilities. - **Synthetic Yeast Genome**: Macquarie University researchers created the first synthetic yeast genome, showcasing potential for resilient organisms in food and medicine production. - **Biofoundries**: Increasingly being established for efficient genetic engineering and biomanufacturing. - **Synthetic Biology Advancements**: Esphera SynBio's $2 million seed financing aims to develop a cancer vaccine using engineered exosomes. - **Cloud-Connected Bioreactors**: Innovative technology enhancing biomanufacturing processes, allowing for cost-effective natural product synthesis. - **Microbial Biotechnology**: Engineered yeast cells functioning as microscopic factories for producing therapeutic compounds and responding to disease markers. - **Generative AI in Healthcare**: Transforming drug discovery, clinical trials, and personalized medicine through synthetic data generation. - **ROSALIND Biosensor**: A new biosensor for detecting water contaminants, combining synthetic biology and nanotechnology. - **Automation in DNA Synthesis**: Integration of automation is transforming the DNA synthesis market, enhancing efficiency and precision. - **AI and Machine Learning**: Significant opportunities in optimizing DNA synthesis and drug discovery processes. - **Enzymatic DNA Synthesis**: The market is growing due to rising demand for DNA-based therapeutics and vaccines, with advancements in personalized medicine. - **ExFAB at UC Santa Barbara**: The first biofoundry in the U.S. dedicated to extreme microbes, aiming to unlock new possibilities in synthetic biology. - **Bioprinting**: Combines 3D printing with cellular biology to create tissues and organs, advancing personalized medicine and organ transplantation. - **Enzymatic DNA Synthesis Market Growth**: Driven by demand for eco-friendly processes and advancements in biotechnology. - **Trogenix's Synthetic Super-Enhancer Technology**: Aiming to revolutionize cancer treatment by targeting aggressive cancers while sparing healthy cells. ### Challenges and Concerns - **Regulatory Complexities**: Challenges in navigating regulatory requirements for synthetic biology applications. - **Ethical Considerations**: The rapid advancement of synthetic biology raises ethical concerns regarding genetic manipulation and its implications for biodiversity. - **High R&D Costs**: Significant financial investment required for research and development in synthetic biology. - **Regulatory Challenges**: Complex regulatory requirements can hinder the growth and application of synthetic biology technologies. - **Regulatory Hurdles**: Navigating regulatory frameworks for synthetic biology products can be complex and may hinder innovation. - **Cost of DNA Synthesis**: Despite advancements, cost-effective synthesis of DNA remains a significant hurdle in synthetic biology. - **Public Acceptance**: There is a need for public education and acceptance of synthetic biology applications to ensure successful integration into healthcare. - **Intellectual Property Complexities**: Navigating intellectual property rights remains a challenge for companies in the synthetic biology sector. - **Technical Challenges**: Despite positive market growth, technical barriers remain significant, hindering the advancement of synthetic biology applications. - **Talent Shortage**: The synthetic biology market faces challenges due to a shortage of skilled professionals, hindering research and innovation. - **Healthcare Access**: Limited access to healthcare in developing countries poses challenges for the widespread adoption of synthetic biology solutions. - **Socioeconomic Disparities**: Barriers to accessible education in synthetic biology limit opportunities for hands-on learning and innovation across diverse populations. - **Data-Centric Hazards**: Risks associated with the misuse of data-centric approaches in synthetic biology, including potential bioterrorism and ecological disruption. - **Regulatory and Ethical Concerns**: Challenges related to genetic manipulation and the need for evolving regulatory frameworks. - **High Initial Investment Costs**: The complexity and costs associated with enzymatic DNA synthesis may impede market progress. - **Data Privacy**: Concerns regarding the use of synthetic data and the need for robust governance in AI applications. - **Ethical Dilemmas**: Concerns regarding data ownership and implications for healthcare innovation, particularly with gene editing technologies.